Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 19Terminated 4Unknown 2Recruiting 2Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myeloid, Acute 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia, Lymphocytic, Chronic, B-Cell 2Recurrence 1Prostatic Neoplasms 1Philadelphia Chromosome 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia 1Hematologic Neoplasms 1Bronchiolitis Obliterans Syndrome 1Breast Neoplasms 1

Interventions

Cyclophosphamide 10fludarabine phosphate 9Rituximab 9Cytarabine 9Peripheral Blood Stem Cell Transplantation 8Methotrexate 8Filgrastim 6Cyclosporine 6fludarabine 5Radiotherapy 5Busulfan 5Tacrolimus 4Mycophenolic Acid 4Idarubicin 4Granulocyte Colony-Stimulating Factor 4Bendamustine Hydrochloride 4venetoclax 3duvelisib 3Whole-Body Irradiation 3Sirolimus 3Melphalan 3Antilymphocyte Serum 3Prednisone 2N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine 2Mitoxantrone 2Lenalidomide 2Interferon-alpha 2Drug Therapy 2Clofarabine 2Arsenic Trioxide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Leukemia × Dasatinib × Clear all
NCT00829647 2019-04-11

A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic Leukemia

Scripps Health

Phase 1/2 Withdrawn
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡